.Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J05A_DirectActingAntivirals.J05AX26_Amenamevir.Amenamevir

Information

name:Amenamevir
ATC code:J05AX26
route:oral
n-compartments2

Amenamevir is an orally active helicase-primase inhibitor used for the treatment of herpes zoster (shingles) in adults. It is approved and marketed in Japan for this indication. Amenamevir inhibits the helicase-primase complex essential for herpesvirus DNA replication.

Pharmacokinetics

Pharmacokinetic parameters reported for healthy adult Japanese volunteers receiving single oral doses of amenamevir.

References

    Revisions

    Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos